Chengdu Kanghong Pharmaceutical Group Co., Ltd (SZSE: 002773)
Health Care · Pharmaceuticals · CN
CN¥21.80
+6.76% today · -40.5% 1Y
Chengdu Kanghong Pharmaceutical Group Co., Ltd (SZSE: 002773) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.99B and employs 4,470 people.
Over the last twelve months the share price has lost 40.5%, trading between 18.62 and 37.77.
Tweenvest scores Chengdu Kanghong Pharmaceutical Group Co., Ltd across four factors: quality 87/100, value 47/100, growth 67/100, dividend 74/100. Its strongest factor is quality.
002773 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.99B
- Revenue (TTM)
- $634.59M
- P/E
- 20.18
- EPS
- 1.08
- Dividend yield
- 3.21%
- Beta (5Y)
- -0.21
- 52-week high
- CN¥37.77
- 52-week low
- CN¥18.62
- Avg volume (3M)
- —
- Shares outstanding
- 921.33M
- Employees
- 4,470
- Next earnings
- —
About Chengdu Kanghong Pharmaceutical Group Co., Ltd
Chengdu Kanghong Pharmaceuticals Group Co., Ltd operates within China, focusing on the research, development, production, and marketing of a wide array of pharmaceutical goods. These include biologics, traditional Chinese medicines, and chemical drugs. The company's offerings span treatments for ophthalmic ailments, central nervous system conditions, digestive disorders, and other therapeutic areas. Founded in 1996, its corporate headquarters are located in Chengdu, China.
- ISIN
- CNE1000020C4
- Founded
- 1996
- Listed since
- Jun 29, 2015
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Sunshine Lake Pharma Co., Ltd.SEHK: 6887 | $3.09B | HK$42.12 | +6.36% |
| Guangdong Zhongsheng Pharmaceutical Co., Ltd.SZSE: 002317 | $3.04B | CN¥24.03 | +2.91% |
| Jilin Aodong Pharmaceutical Group Co., Ltd.SZSE: 000623 | $3.04B | CN¥17.41 | -0.40% |
| Enliven Therapeutics, Inc.NasdaqGS: ELVN | $3.03B | $40.42 | -2.27% |
| Virbac SAENXTPA: VIRP | $2.98B | €315.50 | -0.79% |
| Neuland Laboratories LimitedBSE: 524558 | $2.86B | Rs21,496.30 | -1.86% |
| MBX Biosciences, Inc.NasdaqGS: MBX | $2.82B | $52.42 | -10.41% |
| Rubicon Research LimitedNSEI: RUBICON | $2.80B | Rs1,630.90 | -2.71% |
Figures last refreshed Oct 4, 2026.